SCD and gastric cancer: By using in vivo, in vitro, and in silico methods, our results revealed that SCD1 was an oncogene in gastric cancer, and exhibited the ability to ameliorate metastasis, anti-ferroptotic cell death and growth of gastric cancer cells in vitro and in vivo.